Get 33% Off Our Royal Products 👑

*Excludes existing offers & subscriptions. Discount applied automatically within the checkout. Available from the 6th to 8th May 2023 

☃️ Christmas Orders 🎁

Last orders for dispatch before Xmas will be Wednesday 21st December. 🎅 All orders after this date will be fulfilled from the 4th of January 2023. In the meantime, we wish you a merry Christmas 🎄 and a happy New Year

3 for 2 Mix & Match Offer

*Cheapest item for free is applied automatically within the checkout. Available til the end of Jan 2023
**Excludes existing offers,  discounts & subscriptions.

20% Off Sale Women’s Probiotics

💘 Available from the 8th March to the 19th March on our three most popular women’s probiotics. 💘
💗 Discount added automatically at checkout for you. 💗

ProVen Probiotics'
own research

Dedicated to supporting the efficacy and effectiveness of our product range.

ProVen clinical

As part of Cultech Ltd, the bioscience company based in South Wales in the UK, ProVen Probiotics has access to a team of around 15 research scientists who have been committed to research of the microbiome and probiotics for more than 30 years and are continuously involved in clinical research and product development.

Owned by Dr Nigel Plummer, Cultech and ProVen are both research-led companies, ProVen having been established to bring research-backed probiotics products to the general public to help support their microbiome and thus their health. We now have more than 100 published articles, research papers and posters related to the gut, the microbiome and Lab4 probiotics (the proprietary group of bacteria contained in most of our products).

The products developed for the ProVen Probiotics range are all based upon clinical research into the specific blends of bacteria used in the products. Summaries of and links to the studies are included below.


The randomised, double-blind, placebo-controlled study aimed to assess the effect of 6-month supplementation with the Lab4P probiotic on body weight, cholesterol levels, coughs and colds and well-being in healthy overweight and obese individuals. 220 adults aged 30-65 years with BMI 25-34.9 received a daily dose of either 50 billion Lab4P probiotics or a matching placebo with no other changes to their diet or lifestyle throughout the study period. The Lab4P probiotic supplementation significantly reduced bodyweight by 1.5% in the overweight and obese adults. Greater reduction in bodyweight loss was observed in the overweight adults (1.9%), adults over 50 years old (2%) and adults with high cholesterol levels (2.5%). The levels of atherogenic small dense LDL (‘bad’) cholesterol were significantly reduced in response to the Lab4P probiotics. The 40% reduction was observed in the incidence of total coughs and colds symptoms, together with the improvements in Quality of Life scores of general wellness, health, energy and mood. Lab4P probiotics demonstrated a protective role in reducing the incidence of viral specific upper respiratory tract infection symptoms particularly in older or obese adults and preventing changes in gut microbiota composition in the older participants who developed URTI symptoms (2021 publication). In conclusion, the supplementation with Lab4P probiotics is beneficial in the weight management, immune support and quality of life.
Read More Here

Get in touch

Looking for more information on our clinical trials and research & development?
Click the contact us button below and we’ll get back to you as soon as possible.

Scroll to Top